Lombard Odier Asset Management »

Arrowhead Pharmaceuticals In Note 1/1 shares owned by Lombard Odier Asset Management

Quarter-by-quarter ownership of Arrowhead Pharmaceuticals In Note 1/1 shares owned by Lombard Odier Asset Management from 13F filings

Historical chart of Lombard Odier Asset Management investment in Arrowhead Pharmaceuticals In Note 1/1

Tip: Access up to 7 years of quarterly data

All positions including Arrowhead Pharmaceuticals In Note 1/1 held by Lombard Odier Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Arrowhead Pharmaceuticals In Note 1/1 by Lombard Odier Asset Management

Quarter filed Position value Share count Share price at filing
2026-06-30 $10M 8.5M 1.20

More positions owned by Lombard Odier Asset Management

NVIDIA Corporation (NVDA)
Alphabet Cap Stk Cl A Call Option (GOOGL)
Snowflake Note 10/0 (Principal)
Cyberark Software Note 6/1 (Principal)
Cloudflare Note 6/1 (Principal)
Akamai Technologies Note 0.250% 5/1 (Principal)
Amazon (AMZN)
Jd.com Note 0.250% 6/0 (Principal)
Uber Technologies Note 0.875%12/0 (Principal)
Micron Technology (MU)
Centerpoint Energy Note 4.250% 8/1 (Principal)
Halozyme Therapeutics Note 1.000% 8/1 (Principal)
Live Nation Entertainment In Note 2.875% 1/1 (Principal)
Datadog Note 12/0 (Principal)
Waste Management (WM)

View all positions for Lombard Odier Asset Management

Top funds holding Arrowhead Pharmaceuticals In Note 1/1

Deerfield Management Company
Camden Asset Management
LMR Partners
Linden Advisors
Ubs Global Asset Management Americas
Readystate Asset Management
Lazard Asset Management
Calamos Advisors
MacKay Shields
DeepCurrents Investment Group
Context Capital Management
Advent Capital Management
State Street Corporation
DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main
Oaktree Capital Management

View all funds holding Arrowhead Pharmaceuticals In Note 1/1